Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

Summary

The purpose of this study is to compare concomitant administration of Montelukast and Bilastine to Montelukast and Bilastine monotherapies in patients with SARC and asthma

Timeline

Start

2016-04-13

Primary completion

2016-11-24

Completion

2016-11-24

Outcome

Missed primary endpoint

registry analysis (superiority test); Bilastine+Montelukast vs Bilastine Monotherapy; p = 0.5721; Mean Difference (Final Values) -0.194 (95% CI -0.8693 to 0.4813); ANCOVA NCT02761252 ↗

Drugs

Indications